News | December 04, 2025
The company introduced the ExcelSign E12 and E17 modular patient monitors, the Relife 1000 biphasic defibrillator, and a new OT charting software
Angelini Ventures has already invested €125 million in 22 startups
The platform integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
Owlet’s push comes as parents demand smarter, more dependable nursery tech
The fresh capital will propel Cordance into its first-in-human clinical trial
Renalyx will continue operating as an independent unit within the group
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Sapala Organics
Subscribe To Our Newsletter & Stay Updated
